Omega Healthcare Investors(US:OHI)2025-10-30 20:16Financial Performance - Omega Healthcare Investors reported a net income of $185 million, or $0.59 per diluted share, for Q3 2025, compared to $115 million, or $0.42 per diluted share, for Q3 2024[4]. - Total revenues for the three months ended September 30, 2025, increased to $311.6 million, up 12.9% from $276.0 million in the same period of 2024[38]. - Net income for the three months ended September 30, 2025, was $184.96 million, representing a 61.0% increase compared to $114.91 million in the prior year[40]. - Nareit Funds From Operations (FFO) for the three months ended September 30, 2025, reached $241.81 million, a 23.4% increase from $196.07 million in the same quarter of 2024[40]. - Adjusted Funds From Operations (AFFO) for the three months ended September 30, 2025, amounted to $242.77 million, compared to $203.07 million in the same period of 2024, reflecting a 19.5% increase[40]. - Earnings per common share for the three months ended September 30, 2025, were $0.60, up from $0.43 in the same quarter of 2024, marking a 39.5% increase[38]. - The company reported a net income available to common stockholders of $179.72 million for the three months ended September 30, 2025, compared to $111.76 million in the prior year, an increase of 60.8%[40]. - Funds Available for Distribution (FAD) for the nine months ended September 30, 2025, totaled $665.28 million, compared to $536.92 million in the same period of 2024, indicating a 24.0% increase[40]. Adjusted Funds From Operations (AFFO) Guidance - Adjusted Funds From Operations (AFFO) for the quarter were $243 million, or $0.79 per diluted share, up from $203 million, or $0.74 per diluted share, in Q3 2024[4]. - Omega increased its 2025 AFFO guidance to a range of $3.08 to $3.10 per diluted share, up from the previous range of $3.04 to $3.07 per diluted share[25]. Investments and Acquisitions - The company completed approximately $151 million in new investments during Q3 2025, including $67 million in real estate acquisitions and $76 million in other investments[4]. - The company acquired a 49% equity interest in a joint venture with Saber Healthcare for $222 million, which includes a portfolio of 64 facilities generating $69.4 million in annual contractual rent[10]. - The company sold 11 facilities for $81.1 million in cash during Q3 2025, recognizing a gain of $28.2 million[12]. Debt and Liabilities - The company entered into a new $2.3 billion senior unsecured credit facility, replacing a previous $1.45 billion facility[4]. - Omega repaid $600 million of senior unsecured notes at par value on October 15, 2025[21]. - As of September 30, 2025, Omega had $5.0 billion in outstanding indebtedness with a weighted average interest rate of 4.6%[23]. - The total liabilities of the Company stood at $5,351,936,000 as of September 30, 2025, compared to $5,167,052,000 at the end of 2024, indicating an increase of about 3.6%[36]. - The repayment of a $245,900,000 GBP denominated secured mortgage loan is scheduled for around November 25, 2025, using proceeds from the 2028 Term Loan[27]. Assets and Equity - The Company reported total real estate assets of $9,614,373,000 as of September 30, 2025, an increase from $9,060,174,000 as of December 31, 2024, reflecting a growth of approximately 6.1%[36]. - Total stockholders' equity increased to $5,036,128,000 from $4,536,673,000, marking a growth of approximately 11%[36]. - Cash and cash equivalents increased to $737,186,000 from $518,340,000, representing a significant rise of about 42.3%[36]. - Omega's total cash and cash equivalents were $737.2 million as of September 30, 2025, with $2.0 billion in undrawn capacity under its Revolving Credit Facility[23]. Operational Insights - The Company operates a diverse portfolio primarily in skilled nursing and assisted living facilities across the U.S. and the U.K.[30]. - The Company expects general and administrative expenses for the fourth quarter to be between $13,500,000 and $14,500,000[27]. - Approximately $56,000,000 of the $209,000,000 in mortgages and other real estate-backed investments maturing in 2025 will be converted from loans to fee simple real estate[27]. - The Company has approximately $15,000,000 in asset sales planned[27]. Upcoming Events - The Company will conduct a conference call on October 31, 2025, to discuss its third quarter results and current developments[29].